ArticleGenes & diseases2026

Transcriptomic landscapes underlying response and resistance to HDAC inhibitor chidamide in triple-negative breast cancer.

Yanxia Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.